Ambev (NYSE:ABEV) Now Covered by Analysts at StockNews.com

Equities researchers at StockNews.com started coverage on shares of Ambev (NYSE:ABEV - Get Free Report) in a research note issued to investors on Wednesday. The brokerage set a "buy" rating on the stock.

A number of other research analysts have also weighed in on ABEV. Barclays decreased their target price on Ambev from $2.50 to $2.00 and set an "equal weight" rating on the stock in a report on Tuesday, January 21st. UBS Group lowered shares of Ambev from a "buy" rating to a "neutral" rating in a research report on Tuesday, April 22nd. Citigroup reissued a "neutral" rating on shares of Ambev in a research report on Wednesday, January 22nd. Bank of America lowered shares of Ambev from a "buy" rating to a "neutral" rating in a research report on Friday, January 17th. Finally, Morgan Stanley lowered shares of Ambev from an "equal weight" rating to an "underweight" rating in a research report on Monday, April 7th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $2.45.

Ambev Stock Up 0.8 %

Shares of NYSE:ABEV traded up $0.02 during trading on Wednesday, hitting $2.49. 31,596,082 shares of the company were exchanged, compared to its average volume of 28,303,080. The stock has a market cap of $39.24 billion, a price-to-earnings ratio of 13.83, a P/E/G ratio of 5.80 and a beta of 0.68. Ambev has a fifty-two week low of $1.76 and a fifty-two week high of $2.56. The firm has a fifty day moving average price of $2.26 and a two-hundred day moving average price of $2.12. The company has a current ratio of 1.20, a quick ratio of 0.89 and a debt-to-equity ratio of 0.02.

Ambev (NYSE:ABEV - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.01). The company had revenue of $4.63 billion for the quarter, compared to analyst estimates of $22.42 billion. Ambev had a return on equity of 16.12% and a net margin of 17.02%. As a group, research analysts anticipate that Ambev will post 0.18 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Ambev

Several hedge funds have recently bought and sold shares of ABEV. Insight Inv LLC bought a new position in Ambev in the 4th quarter valued at about $25,000. GAMMA Investing LLC boosted its stake in shares of Ambev by 468.4% in the 1st quarter. GAMMA Investing LLC now owns 10,998 shares of the company's stock valued at $26,000 after purchasing an additional 9,063 shares in the last quarter. Perigon Wealth Management LLC acquired a new stake in shares of Ambev in the 1st quarter valued at approximately $27,000. Generation Capital Management LLC acquired a new stake in shares of Ambev in the 4th quarter valued at approximately $28,000. Finally, Naviter Wealth LLC acquired a new stake in shares of Ambev in the 4th quarter valued at approximately $29,000. 8.13% of the stock is owned by institutional investors.

About Ambev

Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.